{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:16:11Z","timestamp":1792113371862,"version":"4.4.0"},"reference-count":33,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"unspecified","delay-in-days":147,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2025,5,13]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine the feasibility and risk of flares by achieving successful glucocorticoid (GC) tapering during the first year of juvenile SLE and the value of early achievement of childhood lupus low disease activity state (cLLDAS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The medical charts of children with moderate-to-severe SLE between 2012 and 2022 were retrospectively analysed. Successful tapering was defined as the employment of a prednisolone equivalent dose, lower dose of either \u22647.5\u2009mg\/day or \u22640.15\u2009mg\/kg\/day, as per the cLLDAS definition. A linear mixed-effects model was used to determine the fixed effects affecting the GC dose over the first year. Cox regression analysis was used to identify whether successful tapering increased the risk of flares, and logistic regression was used to determine the odds of flares after the twelfth month of treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Successful GC tapering was observed in 50 out of 80 patients (62.5%) within the first year of treatment, and flares were observed in 23 (28.8%) patients. The GC tapering trajectories over time were similar based on flare observations (p&gt;0.05). Furthermore, successful tapering did not increase the risk of flares. Additionally, patients without flares received significantly higher GC doses as the initial treatment (p=0.046). Achievement of cLLDAS was observed in 40 (50%) patients at the twelfth month; however, achievement was not protective against future flares, and positive anti-double-stranded DNA antibodies at the twelfth month increased the odds of flares (OR: 4.8, p=0.008).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Successful GC tapering is feasible and does not increase the risk of flares during the early disease phase. However, flares are common and adversely affect GC tapering. Thus, the identification of children with an increased risk of flares on GC tapering is needed to reduce the GC burden.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/lupus-2024-001415","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T23:20:19Z","timestamp":1748388019000},"page":"e001415","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Glucocorticoid tapering early in the course of juvenile SLE: association with lupus low disease activity state and outcomes"],"prefix":"10.1136","volume":"12","author":[{"given":"Ozge","family":"Baba","sequence":"first","affiliation":[{"name":"Pediatric Rheumatology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1095-3222","authenticated-orcid":false,"given":"Hakan","family":"K\u0131sao\u011flu","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"Unal","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umit","family":"Gul","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology, Istanbul University Istanbul-Cerrahpasa Faculty of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"Basaran","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezgin","family":"Sahin","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology, Istanbul University Istanbul-Cerrahpasa Faculty of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-7720","authenticated-orcid":false,"given":"Ozgur","family":"Kasapcopur","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology, Istanbul University Istanbul-Cerrahpasa Faculty of Medicine, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukaddes","family":"Kalyoncu","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"2025091515164680000_12.1.e001415.1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)00398-2"},{"key":"2025091515164680000_12.1.e001415.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.121"},{"key":"2025091515164680000_12.1.e001415.3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5152\/TurkArchPediatr.2024.24097","article-title":"Revisiting Childhood-Onset Systemic Lupus Erythematosus","volume":"59","author":"Avar-Ayd\u0131n","year":"2024","journal-title":"Turk Arch Pediatr"},{"key":"2025091515164680000_12.1.e001415.4","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/rheumatology\/keae041","article-title":"A path to Glucocorticoid Stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus","volume":"63","author":"Bertsias","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025091515164680000_12.1.e001415.5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa420"},{"key":"2025091515164680000_12.1.e001415.6","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000571","article-title":"LLDAS is an attainable treat-to-target goal in childhood-onset SLE","volume":"8","author":"Wahadat","year":"2021","journal-title":"Lupus Sci Med"},{"key":"2025091515164680000_12.1.e001415.7","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00467-022-05742-8","article-title":"Lupus low disease activity state as a treatment target for pediatric patients with lupus nephritis","volume":"38","author":"Kisaoglu","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"2025091515164680000_12.1.e001415.8","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1093\/rheumatology\/keab915","article-title":"Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus","volume":"61","author":"Smith","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025091515164680000_12.1.e001415.9","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000884","article-title":"Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLE","volume":"10","author":"Cody","year":"2023","journal-title":"Lupus Sci Med"},{"key":"2025091515164680000_12.1.e001415.10","doi-asserted-by":"crossref","first-page":"109296","DOI":"10.1016\/j.clim.2023.109296","article-title":"PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS)","volume":"250","author":"Smith","year":"2023","journal-title":"Clin Immunol"},{"key":"2025091515164680000_12.1.e001415.11","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002701","article-title":"Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study","volume":"8","author":"Floris","year":"2022","journal-title":"RMD Open"},{"key":"2025091515164680000_12.1.e001415.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2025091515164680000_12.1.e001415.13","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2025091515164680000_12.1.e001415.14","first-page":"453","article-title":"International consensus for a definition of disease flare in lupus","volume":"20","author":"Ruperto","year":"2011","journal-title":"Lupus (Los Angel)"},{"key":"2025091515164680000_12.1.e001415.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390303"},{"key":"2025091515164680000_12.1.e001415.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210960"},{"key":"2025091515164680000_12.1.e001415.17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/art.41930","article-title":"International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis","volume":"74","author":"Chalhoub","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2025091515164680000_12.1.e001415.18","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224762"},{"key":"2025091515164680000_12.1.e001415.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102898"},{"key":"2025091515164680000_12.1.e001415.20","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/art.42920","article-title":"Impact of Glucocorticoid Dose on Complete Response, Serious Infections, and Mortality During the Initial Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis of the Control Arms of Randomized Controlled Trials","volume":"76","author":"Figueroa-Parra","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2025091515164680000_12.1.e001415.21","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30037-2"},{"key":"2025091515164680000_12.1.e001415.22","doi-asserted-by":"crossref","first-page":"110172","DOI":"10.1016\/j.clim.2024.110172","article-title":"First validation of the childhood lupus low disease activity state (cLLDAS) definition in a real-life longitudinal cSLE cohort","volume":"262","author":"Bergkamp","year":"2024","journal-title":"Clin Immunol"},{"key":"2025091515164680000_12.1.e001415.23","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2023-0900"},{"key":"2025091515164680000_12.1.e001415.24","doi-asserted-by":"crossref","first-page":"SI114","DOI":"10.1093\/rheumatology\/kead647","article-title":"Impact of serological activity on flare following clinically inactive disease and remission in childhood-onset systemic lupus erythematosus","volume":"63","author":"Kisaoglu","year":"2024","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2025091515164680000_12.1.e001415.25","doi-asserted-by":"crossref","first-page":"103374","DOI":"10.1016\/j.autrev.2023.103374","article-title":"Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenon","volume":"22","author":"Ceccarelli","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2025091515164680000_12.1.e001415.26","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205171"},{"key":"2025091515164680000_12.1.e001415.27","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000590","article-title":"Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies","volume":"8","author":"Ugarte-Gil","year":"2021","journal-title":"Lupus Sci Med"},{"key":"2025091515164680000_12.1.e001415.28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/rheumatology\/keac419","article-title":"Predictors and prognostic stratification for lupus low disease activity state: results from a prospective clinical trial","volume":"62","author":"Zhang","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025091515164680000_12.1.e001415.29","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/acr.23531","article-title":"Measuring Disease Damage and Its Severity in Childhood\u2010Onset Systemic Lupus Erythematosus","volume":"70","author":"Holland","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025091515164680000_12.1.e001415.30","doi-asserted-by":"crossref","first-page":"152516","DOI":"10.1016\/j.semarthrit.2024.152516","article-title":"Real-world application of the pediatric Glucocorticoid Toxicity Index in childhood-onset lupus","volume":"68","author":"Zhang","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"2025091515164680000_12.1.e001415.31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker306"},{"key":"2025091515164680000_12.1.e001415.32","doi-asserted-by":"publisher","DOI":"10.1002\/art.24469"},{"key":"2025091515164680000_12.1.e001415.33","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217632","article-title":"Physician global assessment in systemic lupus erythematosus: can we rely on its reliability?","volume":"81","author":"Chessa","year":"2022","journal-title":"Ann Rheum Dis"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2024-001415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:16:55Z","timestamp":1757974615000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2024-001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,5,27]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/lupus-2024-001415"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2024-001415","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}